Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer

Author： Haas R.   Schmid H.   Hahn U.   Hohaus S.   Goldschmidt H.   Murea S.   Kaufmann M.   Wannenmacher M.   Wallwiener D.   Bastert G.   Hunstein W.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.33, Iss.3, 1997-03, pp. : 372-378

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers

By Yeh K-H.   Lin M-T.   Lin D-T.   Tang J-L.   Lui L-T.   Lin J-F.   Chang Y-S.   Cheng A-L.   Yu S-C.   Chang K-J.   Chen Y-C.  

Breast Cancer Research and Treatment, Vol. 49, Iss. 3, 1998-06 ,pp. : 237-244

Springer Publishing Company

Access to resources Recommend Favorite

The Toxicity of Radiotherapy Following High-dose Chemotherapy With Peripheral Blood Stem Cell Support in High-risk Breast Cancer: A Preliminary Analysis

By van der Wall E.   Schaake-Koning C.C.E.   van Zandwijk N.   Baars J.W.   Schornagel J.H.   Richel D.J.   Rutgers E.J.T.   Borger J.H.   Beijnen J.H.   Rodenhuis S.  

European Journal of Cancer, Vol. 32, Iss. 9, 1996-08 ,pp. : 1490-1497

Elsevier

Access to resources Recommend Favorite

A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer

By Gluck S.   Germond C.   Lopez P.   Cano P.   Dorreen M.   Koski T.   Arnold A.   Dulude H.   Gallant G.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1008-1014

Elsevier

Access to resources Recommend Favorite

Repetitive High-Dose Topotecan, Carboplatin, and Paclitaxel with Peripheral Blood Progenitor Cell Support in Previously Untreated Ovarian Cancer: Results of a Phase I Study

By Prince H.M.   Rischin D.   Quinn M.   Allen D.   Planner R.   Neesham D.   Gates P.   Davison J.  

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 216-224

Elsevier

Access to resources Recommend Favorite

Acute and Late Toxicity Following Adjuvant High-Dose Chemotherapy for High-Risk Primary Operable Breast Cancer A Quality Assessment Study

By Svane Inge M.   Homburg Keld M.   Kamby Claus   Nielsen Dorte L.   Roer Ole   Sliffsgaard Dorte   Johnsen Hans E.   Hansen Steen W.  

Acta Oncologica, Vol. 41, Iss. 7-8, 2002-11 ,pp. : 675-683

Informa Healthcare

Access to resources Recommend Favorite